Use of glutaraldehyde treated autologous human erythrocytes for hepatic targeting of doxorubicin.
Tonetti
M
M
Institute of Biochemistry, University of Genoa, Italy.
Zocchi
E
E
Guida
L
L
Polvani
C
C
Benatti
U
U
Biassoni
P
P
Romei
F
F
Guglielmi
A
A
Aschele
C
C
Sobrero
A
A
D015179:Colorectal Neoplasms / Q000473:pathology; D004317:Doxorubicin / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D004337:Drug Carriers; D004910:Erythrocyte Membrane / Q000187:drug effects*; D005976:Glutaral; D006801:Humans; D066298:In Vitro Techniques; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000556:secondary; D008297:Male; D008875:Middle Aged; D013670:Sodium Pertechnetate Tc 99m
D004337:Drug Carriers; D004317:Doxorubicin; D013670:Sodium Pertechnetate Tc 99m; D005976:Glutaral